Medical : IHL Impression Healthcare
Zitat:"Cannvalate chief executive officer and co-founder Dr Sud Agarwal described the clinical trials as potentially ?game-changing? since all four of these diseases have ?no existing therapies available today?.
The trials are also expected to leverage Impression?s existing intellectual property and profile within both the dental industry and sporting communities.
Parallel to its emergence in the medical cannabis sector, the company has a range of dental health products and a keen involvement in Australia?s sporting industry, with its Gameday Mouthguards becoming an official licensee of the Australian Football League (AFL) back in August 2018.
In addition, the collaboration paves the way for Impression to advance talks with a Canadian cannabis oil producer for the potential distribution of its oils through Cannvalate?s network...." ENDE Zitat